Orion Infusion Limited (DSE:ORIONINFU)

Orion Infusion Revenue

Orion Infusion had revenue of 228.94M BDT in the quarter ending December 31, 2025, with 17.38% growth. This brings the company's revenue in the last twelve months to 665.43M, down -14.96% year-over-year. In the fiscal year ending June 30, 2025, Orion Infusion had annual revenue of 664.92M, down -19.64%.

• Revenue (ttm): 665.43M
• Revenue Growth: -14.96%
• P/S Ratio: 9.48
• Revenue / Employee: 1.18M
• Employees: 563
• Market Cap: 6.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	664.92M	-162.50M	-19.64%
Jun 30, 2024	827.42M	17.26M	2.13%
Jun 30, 2023	810.15M	-19.42M	-2.34%
Jun 30, 2022	829.57M	102.17M	14.05%
Jun 30, 2021	727.40M	-13.47M	-1.82%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error